negative! the drug never failed. due yur dd an read up on the catalyst sequence. im not going to explain all this, but in a quick summary acad was not ready for the nda, so it got a delay, they then followed up an it was completed correctly. this is a potential blockbuster breakthrough drug, the only one of its kind. there is a ton of information out there, read up like all of us have. im hoping you do not invest on other peoples posts, but based on your own decision an dd. gl
News 
Market Data 
Discover 
